Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters — María Rescigno (2023) | RDL Network
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
Article 2023 en
Authors
MR
María Rescigno
CA
Chiara Agrati
CS
Carlo Salvarani
Abstract
1 min read
These data support the recommendation of additional booster doses in frail patients to enhance the development of a B-cell response directed against Omicron and/or to enhance the T-cell response in patients treated with anti-CD20.
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.